Time course and attenuation of ischaemia-reperfusion induced oxidative injury by propofol in human renal transplantation

REFERENCES

• Rodeck G, Lange H. Indications and contraindications for kidney transplantation. Urologe 1982; 21: 244–248.
   PubMed Web of Science ®Google Scholar
• Kissmeyer-Nielsen F, Olsen S, Petersen Vg Fjeldborg O. Hyperacute rejection of kidney allografts, associated with pre-existing humoral antibodies against donor cells. Lancet 1966; 2: 662–665.
   PubMed Web of Science ®Google Scholar
• Paul LC. Chronic allograft nephropathy: an update. Kidney Int 1999; 56: 783–793.
   PubMed Web of Science ®Google Scholar
• Paller MS. Free radical-mediated postischemic injury in renal transplantation. Ren Fail 1992; 14: 257–260.
   PubMed Web of Science ®Google Scholar
• Paller MS, Greene EL. Role of calcium in reperfusion injury of the kidney. Ann NY Acad Sci 1994; 723: 59–70.
   PubMed Web of Science ®Google Scholar
• Webster NR, Nunn JF. Molecular structure of free radicals and their importance in biological reactions. Br J Anaesth 1988; 60: 98–108.
   PubMed Web of Science ®Google Scholar
• Vural A, Yilmaz MI, Caglar K et al. Assessment of oxidative stress in the early posttransplant period: comparison of cyclosporine A and tacrolimus-based regimens. Am J Nephrol 2005; 25: 250–255.
   PubMed Web of Science ®Google Scholar
• Basu S. Oxidative injury induced cyclooxygenase activation in experimental hepatotoxicity. Biochem Biophys Res Commun 1999; 254: 764–767.
   PubMed Web of Science ®Google Scholar
• Kadiiska MB, Gladen BC, Baird DB et al. II. Biomarker of oxidative stress study: are oxidation products of lipids, proteins and DNA markers in CC14 poisoning? Free Radic Biol Med 2005; 38: 698–710.
   Google Scholar
• Morrow JD, Hill KE, Burk RF, Nammour TM, Badr KF, Roberts 2nd U. A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci USA 1990; 87: 9383–9387.
   PubMed Web of Science ®Google Scholar
• Kadiiska MB, Gladen BC, Baird DB et al. II. Biomarker of oxidative stress study: effects of NSAIDs, indomethacin and meclofenamic acid on measurements of oxidative products lipids in CC14 poisoning. Free Radic Biol Med 2005; 38: 711–718.
   PubMed Web of Science ®Google Scholar
• Morrow JD, Roberts 2nd U. The isoprostanes. Current knowledge and directions for future research. Biochem Pharmacol 1996; 51: 1–9.
   PubMed Web of Science ®Google Scholar
• Basu S. Isoprostanes: novel bioactive compounds of lipid peroxidation. Free Radic Res 2004; 38: 105–122.
   PubMed Web of Science ®Google Scholar
• Morrow JD. Quantification of isoprostanes as indices of oxidant stress and the risk of atherosclerosis in humans. Arterioscler Thrombos Vasc Biol 2005; 25: 275–286.
   Google Scholar
• Helmersson J, Vessby B, Larsson A, Basu S. Association of type 2 diabetes with cyclooxygenase-mediated inflammation and oxidative stress in an elderly population. Circulation 2004; 109: 1729–1734.
   PubMed Web of Science ®Google Scholar
• Basu S, Eriksson M. Oxidative injury and survival during endotoxemia. FEBS Lett 1998; 438: 159–160.
   PubMed Web of Science ®Google Scholar
• Basu S, Nozari A, Liu XL, Rubertsson S, Wiklund L. Development of a novel biomarker of free radical damage in reperfusion injury after cardiac arrest. FEBS Lett 2000; 470: 1–6.
   PubMed Web of Science ®Google Scholar
• Basu S, Whiteman M, Mattey DL, Halliwell B. Raised levels of F(2)-isoprostanes and prostaglandin F(2alpha) in different rheumatic diseases. Ann Rheum Dis 2001; 60: 627–631.
   PubMed Web of Science ®Google Scholar
• Ulus AT, Aksovek A, Ozkan M, Katircioglu SF, Basu S. Cardiopulmonary bypass as a cause of free radical induced-oxidative stress and enhanced circulatory isoprostanes in humans. Free Radic Biol Med 2003; 34: 911–917.
   PubMed Web of Science ®Google Scholar
• Samuelsson B, Goldyne M, Granstrom E, Hamberg M, Hammarstrom S, Malmsten C. Prostaglandins and thromboxanes. Annu Rev Biochem 1978; 47: 997–929.
   PubMed Web of Science ®Google Scholar
• Basu S. Novel cyclooxygenase-catalysed bioactive prostaglandin F2c, from physiology to new principles in inflammation. Med Res Rev 2006; 27: 435–468.
   Web of Science ®Google Scholar
• Kosieradzki M, Kuczynska J, Piwowarska J. Prognostic significance of free radicals: mediated injury occurring in the kidney donor. Transplantation 2003; 75: 1221–1227.
   PubMed Web of Science ®Google Scholar
• Richer JP, Gibelin H, Planet M. Ischemia-reperfusion injury is associated with inflammatory cell infiltration: evaluation in a pig kidney autotransplant model. Transplant Proc 2000; 32: 482–483.
   PubMed Web of Science ®Google Scholar
• Cerwenka H, Bacher H, Werkgartner G. Antioxidant treatment during liver resection for alleviation of ischemia-reperfusion injury. Hepatogastroenterology 1998; 45: 777–782.
   PubMed Web of Science ®Google Scholar
• Rabl H, Khoschsorur G, Colombo T. A multivitamin infusion prevents lipid peroxidation and improves transplantation performance. Kidney Int 1993; 43: 912–917.
   PubMed Web of Science ®Google Scholar
• Muratore A, Ribero D, Ferrero A, Bergero R, Capussotti L. Prospective randomized study of steroids in the prevention of ischaemic injury during hepatic resection with pedicle clamping. Br J Surg 2003; 90: 17–22.
   PubMed Web of Science ®Google Scholar
• Basu S, Mutschler DK, Larsson A, Kiiski R, Norgren A, Eriksson M. Propofol (Diprivan-EDTA) counteracts oxidative injury and deterioration of the arterial oxygen tension during experimental septic shock. Resuscitation 2001; 50: 341–348.
   PubMed Web of Science ®Google Scholar
• Basu S. Radioimmunoassay of 8-iso-prostaglandin F2alpha: an index for oxidative injury via free radical catalysed lipid peroxidation. Prostaglandin Leukoc Essent Fatty Acids 1998; 58: 319–325.
   PubMed Web of Science ®Google Scholar
• Basu S. Radioimmunoassay of 15-keto-13,14-dihydro-prostaglandin F2alpha: an index for inflammation via cyclooxygenase catalysed lipid peroxidation. Prostaglandin Leukoc Essent Fatty Acids 1998; 58: 347–352.
   PubMed Web of Science ®Google Scholar
• Buja LM. Myocardial ischemia and reperfusion injury. Cardiovasc Pathol 2005; 14: 170–175.
   PubMed Web of Science ®Google Scholar
• Halliwell B, Gutteridge JCM. Free Radicals in Biology and Medicine. Oxford: Oxford University Press, 1999.
   Google Scholar
• Murphy PG, Myers DS, Davies MJ, Webster NR, Jones JG. The antioxidant potential of propofol (2,6-diisopropylphenol). Br J Anaesth 1992; 68: 613–618.
   PubMed Web of Science ®Google Scholar
• De La Cruz JP, Sedeno G, Carmona A, Sanchez de la Cuesta F. The in vitro effects of propofol on tissular oxidative stress in the rat. Anesth Analg 1998; 87: 1141–1146.
   PubMed Web of Science ®Google Scholar
• Aldemir O, Celebi H, Cevik C, Duzgun E. The effects of propofol or halothane on free radical production after tourniquet induced ischaemia-reperfusion injury during knee arthroplasty. Acta Anaesthesiol Scand 2001; 45: 1221–1225.
   PubMed Web of Science ®Google Scholar
• Kelicen P. Ismailoglu UB, Erdemli O, Sahin-Erdemli I. The effect of propofol and thiopentone on impairment by reactive oxygen species of endothelium-dependent relaxation in rat aortic rings. Eur J Anaesthesiol 1997; 14: 310–315.
   PubMed Web of Science ®Google Scholar
• Kaptanoglu E, Sen S, Beskonakli E et al. Antioxidant actions and early ultrastructural findings of thiopental and propofol in experimental spinal cord injury. J Neurosurg Anesthesiol 2002; 14: 114–122.
   PubMed Web of Science ®Google Scholar
• De La Cruz JP, Zanca A, Carmona JA, de la Cuesta FS. The effect of propofol on oxidative stress in platelets from surgical patients. Anesth Analg 1999; 89: 1050–1055.
   PubMed Web of Science ®Google Scholar
• Kirvela M, Olkkola KT, Rosenberg PH, Yli-Hankala A, Salmela K, Lindgren L. Pharmacokinetics of propofol and haemodynamic changes during induction of anaesthesia in uraemic patients. Br J Anaesth 1992; 69: 178–182.
   Google Scholar